Shadomy S, Wagner G, Carver M
Antimicrob Agents Chemother. 1977 Nov;12(5):609-13. doi: 10.1128/AAC.12.5.609.
Cefaclor (Lilly 99638) and cefatrizine (BL-S640, SK&F 70771) are orally absorbed, broad-spectrum semisynthetic cephalosporins. They were compared in vitro with cephalexin, cephaloglycin, and cepharadine against a variety of aerobic pathogenic bacteria by an agar dilution procedure. Cefaclor and cefatrizine were found to be similar or superior to cephalexin, cephaloglycin, and cephradine in terms of activity against gram-positive cocci other than enterococci. Only cefatrizine demonstrated any potentially useful activity against some susceptible isolates of enterococci. Cefaclor and cefatrizine also were highly active, equally or more so than the other oral cephalosporins, against several gram-negative species including Escherichia coli, Enterobacter aerogenes, and Klebsiella pneumoniae. None of the cephalosporins were particularly active against Enterobacter cloacae. Both cefaclor and cefatrizine were active against Proteus mirabilis; cefatrizine was uniquely active against indolepositive Proteus species.
头孢克洛(礼来99638)和头孢曲嗪(BL-S640,史克必成70771)是口服吸收的广谱半合成头孢菌素。通过琼脂稀释法,将它们与头孢氨苄、头孢匹林和头孢拉定在体外针对多种需氧病原菌进行了比较。结果发现,在针对除肠球菌外的革兰氏阳性球菌的活性方面,头孢克洛和头孢曲嗪与头孢氨苄、头孢匹林和头孢拉定相似或更优。只有头孢曲嗪对一些肠球菌敏感菌株表现出任何潜在的有用活性。头孢克洛和头孢曲嗪对包括大肠杆菌、产气肠杆菌和肺炎克雷伯菌在内的几种革兰氏阴性菌也具有高活性,与其他口服头孢菌素相当或更高。这些头孢菌素对阴沟肠杆菌均无特别活性。头孢克洛和头孢曲嗪对奇异变形杆菌均有活性;头孢曲嗪对吲哚阳性变形杆菌具有独特活性。